Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis
NEVRING
Evaluation of the Efficacy of BOARDING RING Glasses in the Treatment of Vestibular Neuritis
1 other identifier
interventional
51
1 country
2
Brief Summary
Vestibular neuritis is a brutal and continuous dizzying syndrome of peripheral (vestibular) origin without cochlear or other associated involvement. Specifically, vestibular neuritis is inflammation of the nerve that innervates the vestibular canals (the inner ear). It is characterized by the sudden onset of intense and prolonged vertigo accompanied by postural imbalance, nausea and vomiting, without hearing impairment or other neurological symptoms. Vestibular neuritis is the second cause of peripheral vertigo after benign paroxysmal positional vertigo. It represents approximately 7% of patients consulting for vertigo. The purpose of this study is to evaluate if wearing Boarding Ring glasses can be accelerated vestibular compensation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2021
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 2, 2020
CompletedFirst Posted
Study publicly available on registry
December 21, 2020
CompletedStudy Start
First participant enrolled
March 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 17, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 10, 2029
March 19, 2026
March 1, 2026
7 years
October 2, 2020
March 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Variation of the angle of deviation at the Fukuda test between J0 and J7 (value at J0 minus value at J7).
7 day
Secondary Outcomes (8)
Speed of nystagmus
1 year
Alexander's degree of nystagmus
1 year
Duration of hospitalization (for hospitalized patients)
1 year
Anxiety visual analog scale
1 year
Handicap related to Balance Disorders and Vertigo scale (EHTEV questionnaire)
1 year
- +3 more secondary outcomes
Study Arms (3)
Boarding ring glasses
EXPERIMENTALRealization of the following examinations WITH Boarding ring glasses : * caloric tests, * measurement of the speed of Nystagmus, * angle of deviation in Fukuda, * Alexander's degree of nystagmus, * EHTEV and EEV questionnaires, * anxiety VAS
Placebo glasses
PLACEBO COMPARATORRealization of the following examinations WITH Placebo glasses : * caloric tests, * measurement of the speed of Nystagmus, * angle of deviation in Fukuda, * Alexander's degree of nystagmus, * EHTEV and EEV questionnaires, * anxiety VAS
No glasses
OTHERRealization of the following examinations WITHOUT glasses : * caloric tests, * measurement of the speed of Nystagmus, * angle of deviation in Fukuda, * Alexander's degree of nystagmus, * EHTEV and EEV questionnaires, * anxiety VAS
Interventions
A helmet with an infrared camera will be placed in front of patient eyes. This will allow visualizing on screen and measuring eye movements spontaneous or induced in the dark by various tests.
The patient will be asked to trample on the spot (30 steps) with the indexes pointed forward. In the event of vestibular asymmetry, the patient turns at a varying angle to the right or to the left. This will then measure what is called the angle of deflection of the fukuda.
there are 3 degrees: * Degree I: nystagmus that exists only when the eyes are turned to the right. * Degree II: also exists when the eyes are to the right or to the front. * Degree Ill: exists when the eyes are on the right, front, or left
Handicap Scale for Balance Disorders and Vertigo
European Vertigo Assessment Questionnaire
Lying, patientwill be placed so that he can introduce water (hot then cold) into his external ear canal. It is the reaction of the vestibular system (sensory organ responsible for balance) which is then measured with a helmet placed over his eyes and which measures the nystagmus (movement of the eye) which reflects vestibular activity.
Eligibility Criteria
You may qualify if:
- adult patients,
- patient with vestibular neuritis defined by appearance of continuous rotating vertigo with nausea
- patient with spontaneous horizonto-rotating nystagmus beating towards the healthy ear
- patient with a postural deviation towards the affected ear;
- vestibular hyporeflexia measured at the caloric tests greater than 25%
- patient who has given free, enlighten and written consent
You may not qualify if:
- patient with a history of vertigo of vestibular origin or with vertigo developing for more than 4 days
- patient with associated hearing loss or tinnitus
- patient with an motor ocular abnormality of central origin
- patient refusal or inability to consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CHU de Brest
Brest, 29200, France
CH Pays de Morlaix
Morlaix, 29672, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Christophe LECLERE, Dr
University Hospital, Brest
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Only the investigator carrying out the follow-up consultations is blind. After examination by the ENT specialist (otorhinolaryngologist) who will diagnose vestibular neuritis, the patient will be randomized into one of three groups. The clinical follow-up will be performed by another practitioner, who will not know in which arm the patient is included (the patient will come to the consultation without his glasses). Only the practitioner who realized the randomization and the patient will have information about the arm in which they are located.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 2, 2020
First Posted
December 21, 2020
Study Start
March 10, 2021
Primary Completion (Estimated)
March 17, 2028
Study Completion (Estimated)
May 10, 2029
Last Updated
March 19, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will be available after the publication of result and ending fifteen years following the last visit of the last patient
- Access Criteria
- Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.
All collected data that underlie results in a publication